Klaus Knop

Title: Klaus Knop: Innovator in Pharmaceutical Dosage Forms

Introduction

Klaus Knop is a notable inventor based in Langenfeld, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. His work focuses on enhancing the efficacy and delivery of medications.

Latest Patents

Klaus Knop holds a patent for a process related to the manufacturing of a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil. This invention is characterized by a controlled release of nifedipine in the body, while ensuring that candesartan cilexetil is released rapidly. The patent also includes the option for a diuretic to be released immediately, thereby improving the therapeutic outcomes for patients.

Career Highlights

Klaus Knop is associated with Bayer Pharma Aktiengesellschaft, a leading company in the pharmaceutical industry. His work at Bayer has allowed him to focus on innovative solutions that address complex medical needs. His dedication to research and development has positioned him as a key player in the pharmaceutical sector.

Collaborations

Klaus has collaborated with esteemed colleagues such as Adrian Funke and Günter Meyer. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, ultimately leading to advancements in pharmaceutical technologies.

Conclusion

Klaus Knop's contributions to the field of pharmaceuticals, particularly through his innovative patent, demonstrate his commitment to improving medication delivery systems. His work continues to influence the industry and enhance patient care.